Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03883139 · ClinicalTrials.gov registry record · NA

PRISM Intervention Study

A NA study of Autism Spectrum Disorder, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
140
Enrollment target
3
Study locations

NCT03883139 is a NA study of Autism Spectrum Disorder that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 140 participants, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03883139, a NA study of Autism Spectrum Disorder, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
3
Study locations

Study Summary

This research study, Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM), is designed to maximize language outcomes for limited-language preschoolers, thereby lowering the risk of being classified as "minimally verbal" at age 6, by empirically developing a two-stage, 20-week adaptive intervention approach in a real world community settings. If found efficacious, the adaptive intervention design will capitalize on the heterogeneity and evolving status of children with ASD by providing the best intervention (DTT, JASPER and CET) for children who need it (leading to individualized sequences of intervention), only when it is needed (potentially reducing burden on children).

Conditions Studied

Autism Spectrum Disorder

Interventions

  • BEHAVIORAL JASPER
  • BEHAVIORAL DTT (Discrete Trial Training)

Study Locations (3)

California

  • UCLA - Los Angeles

New York

  • University of Rochester - Rochester

Oregon

  • University of Oregon - Eugene

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2021-03-01
Est. Completion 2026-07-31
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03883139

The ClinicalTrials.gov registry entry for NCT03883139 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which JASPER is the first listed.

NCT03883139 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Oregon.

Frequently Asked Questions

What is clinical trial NCT03883139 about?

NCT03883139 is a clinical study titled "PRISM Intervention Study". This research study, Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM), is designed to maximize language outcomes for limited-language preschoolers, thereby lowering the risk of being classified as "minimally verbal" at age 6, by empirically developing...

What is the current status of trial NCT03883139?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2021-03-01. Estimated completion is 2026-07-31.

What conditions does trial NCT03883139 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT03883139?

The interventions under investigation include: JASPER (BEHAVIORAL), DTT (Discrete Trial Training) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03883139?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03883139 being conducted?

This trial has 3 study locations across California, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.